Devices & Diagnostics

Medical device investor Emergent Medical Partners has raised $70M

Life science investment firm Emergent Medical Partners LP has raised nearly $70 million in a […]

Life science investment firm Emergent Medical Partners LP has raised nearly $70 million in a pooled investment fund over the past four-and-a-half years, according to two U.S. Securities and Exchange Commission filings on Thursday (here and here).

The Portolo Valley, California firm led by medical device pioneer Dr. Thomas Fogarty (one of MedCity News readers’ choices for the would-be Mount Rushmore of med tech) takes on device companies in all areas of medicine, with a particular interest in cardiovascular and orthopedic surgery.

Emergent’s portfolio contains Ardian, a medical device company acquired by Medtronic in 2011; Evalve, a cardiac device company acquired by Abbott in 2009; and diagnostic company HeartFlow, among others.

A call to the firm for further detail was not returned.

Shares0
Shares0